Aptus Clinical acquired by Catalyst Clinical Research

Apr. 2022

Client: Aptus Clinical is a full-service CRO with deep expertise in cutting-edge advanced therapies, such as cell and gene therapy, as well as in oncology and rare and orphan diseases

Role: Edgemont Partners acted as exclusive financial advisor to Aptus Clinical in its sale to Catalyst Clinical Research, a portfolio company of NovaQuest

Location: Macclesfield, UK

Sector: Pharmaceutical Services

Lead Banker: Andrew Karlin

View Press Release

acquired by

Get In Touch